Ads
related to: biontech stock
Search results
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 6 days agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders...
Simply Wall St. via Yahoo Finance· 1 day agoKey Insights BioNTech will host its Annual General Meeting on 17th of May CEO Ugur Sahin's total...
What's Going With BioNTech Stock On Monday?
Benzinga· 6 days agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 6 days agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoBioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the...
BioNTech (NASDAQ:BNTX) PT Lowered to $122.00 at BMO Capital Markets
ETF DAILY NEWS· 3 days agoBioNTech (NASDAQ:BNTX – Free Report) had its price objective cut by BMO Capital Markets from $123.00 to $122.00 in a report released on Tuesday morning, Benzinga reports.
BioNTech shares hold rating, price target raised By Investing.com
Investing.com· 5 days agoTuesday, BioNTech SE (NASDAQ:BNTX) shares maintained their Hold rating, but with an updated price...
BMO Capital cuts BioNTech stock target, keeps Outperform By Investing.com
Investing.com· 5 days agoOn Tuesday, BMO Capital Markets adjusted its price target for shares of BioNTech (NASDAQ:BNTX), a...
BioNTech Swings to Net Loss on Lower Covid Vaccine Sales
Market Watch· 7 days agoBioNTech swung to a net loss in the first quarter, when revenue plummeted after a sharp decline in its Covid-19 vaccine sales. The German biotechnology company, listed on ...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 7 days agoGerman Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply ...